Leukemia

Heated Market For Dueling Blood Cancer Drugs Lands BeiGene In Court

Syndax Pharma Posts Additional Data On Clinical Activity, Responses From Early-Stage Leukemia Trial

Biomea Fusion To Start Early-Stage Leukemia Setting Trial With BMF-219

Syndax Pharma Posts Additional Data On Clinical Activity, Responses From Early-Stage Leukemia Trial

Biomea Fusion To Start Early-Stage Leukemia Setting Trial With BMF-219

Aprea Therapeutics Stock Is Trading Higher As Eprenetapopt Triplet Therapy Achieves 37% CR Rate In Leukemia Patients

JNJ's Imbruvica, AbbVie's Venclexta Combo Achieves Progression-Free Survival Of 78.4% Versus Gazyva-Chemo Cocktail In Leukemia Patients

Aprea Therapeutics Stock Is Trading Higher As Eprenetapopt Triplet Therapy Achieves 37% CR Rate In Leukemia Patients

JNJ's Imbruvica, AbbVie's Venclexta Combo Achieves Progression-Free Survival Of 78.4% Versus Gazyva-Chemo Cocktail In Leukemia Patients

Aptose Biosciences Stock Tumbles As Luxeptinib Fails To Impress At EHA2021 Virtual Congress

BeiGene Touts Initial Brukinsa Efficacy, Safety Profile For Leukemia, Compared To Imbruvica

Leukemia Recent News

AbbVie-Roche's Venclexta Shows Progression-Free Survival Of 74% In CLL Patients After Three Years Treatment

Mustang Bio's CAR T Cell Therapy Achieves 93% ORR, 67% CR In Mid-Stage Leukemia Trial

AbbVie's Ibrutinib/Venetoclax Combo Potentially Chemo-free, Fixed-Duration Treatment Option in Leukemia

Aptevo Stock Gains on Encouraging Single-Agent Activity for APVO436 In Leukemia Patients

Curis Shares Drop On Safety Issues From Leukemia Study With CA-4948; Q1 Earnings Missing Estimates

Syndax Pharma Updates On Interim Phase 1 Data From SNDX-5613 Leukemia Trial

Roche, AbbVie, Bristol-Myers Are Latest To Win European Medicines Agency's CHMP Positive Opinion

Verastem Shares Hit Highest Level Since 2015 On Duvelisib Data

Exclusive: Moleculin CEO Says Acute Myeloid Leukemia Candidate Could Be 'Remarkable'

TG Therapeutics Pulling Off The Band-Aid To Keep GENUINE Cancer Study On Track

StreetSweeper Short Bio-Path: 'Unfortunate' Analyst Support, Little Executive Biotech Experience

Lumber Liquidators CEO Diagnosed With 'Very Treatable' Form Of Leukemia

What Sets Juno Therapeutics Inc Apart In Immunotherapy Space?

IBM's Watson Coming to Smartphones Soon (IBM)